These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 9050834)
21. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Hage T; Sebald W; Reinemer P Cell; 1999 Apr; 97(2):271-81. PubMed ID: 10219247 [TBL] [Abstract][Full Text] [Related]
22. Rational design of interleukin-21 antagonist through selective elimination of the gammaC binding epitope. Kang L; Bondensgaard K; Li T; Hartmann R; Hjorth SA J Biol Chem; 2010 Apr; 285(16):12223-31. PubMed ID: 20167599 [TBL] [Abstract][Full Text] [Related]
23. Multisite mutagenesis of interleukin 5 differentiates sites for receptor recognition and receptor activation. Plugariu CG; Wu SJ; Zhang W; Chaiken I Biochemistry; 2000 Dec; 39(48):14939-49. PubMed ID: 11101310 [TBL] [Abstract][Full Text] [Related]
24. Complete mutagenesis of the extracellular domain of interleukin-8 (IL-8) type A receptor identifies charged residues mediating IL-8 binding and signal transduction. Leong SR; Kabakoff RC; Hébert CA J Biol Chem; 1994 Jul; 269(30):19343-8. PubMed ID: 8034699 [TBL] [Abstract][Full Text] [Related]
25. Identification of a soluble, high affinity human interleukin 4 binding protein in normal human urine. Christie G; Dacey I; Weston BJ Cytokine; 1995 May; 7(4):305-10. PubMed ID: 8589259 [TBL] [Abstract][Full Text] [Related]
26. A discontinuous eight-amino acid epitope in human interleukin-3 binds the alpha-chain of its receptor. Bagley CJ; Phillips J; Cambareri B; Vadas MA; Lopez AF J Biol Chem; 1996 Dec; 271(50):31922-8. PubMed ID: 8943237 [TBL] [Abstract][Full Text] [Related]
27. IL-4 receptor complexes containing or lacking the gamma C chain are inhibited by an overlapping set of antagonistic IL-4 mutant proteins. Schnarr B; Ezernieks J; Sebald W; Duschl A Int Immunol; 1997 Jun; 9(6):861-8. PubMed ID: 9199969 [TBL] [Abstract][Full Text] [Related]
28. The interleukin-2 and interleukin-4 receptors studied by molecular modelling. Bamborough P; Hedgecock CJ; Richards WG Structure; 1994 Sep; 2(9):839-51. PubMed ID: 7529123 [TBL] [Abstract][Full Text] [Related]
29. Structure-function analysis of human IL-6: identification of two distinct regions that are important for receptor binding. Hammacher A; Ward LD; Weinstock J; Treutlein H; Yasukawa K; Simpson RJ Protein Sci; 1994 Dec; 3(12):2280-93. PubMed ID: 7538847 [TBL] [Abstract][Full Text] [Related]
30. Structural model of human IL-13 defines the spatial interactions with the IL-13Ralpha/IL-4Ralpha receptor. Zuegg J; Webb DC; Foster PS; Casarotto MG Immunol Cell Biol; 2001 Aug; 79(4):332-9. PubMed ID: 11488979 [TBL] [Abstract][Full Text] [Related]
31. Characterization of the interaction between interleukin-13 and interleukin-13 receptors. Arima K; Sato K; Tanaka G; Kanaji S; Terada T; Honjo E; Kuroki R; Matsuo Y; Izuhara K J Biol Chem; 2005 Jul; 280(26):24915-22. PubMed ID: 15870068 [TBL] [Abstract][Full Text] [Related]
32. A modular interface of IL-4 allows for scalable affinity without affecting specificity for the IL-4 receptor. Kraich M; Klein M; Patiño E; Harrer H; Nickel J; Sebald W; Mueller TD BMC Biol; 2006 Apr; 4():13. PubMed ID: 16640778 [TBL] [Abstract][Full Text] [Related]
34. Dissecting the energetics of an antibody-antigen interface by alanine shaving and molecular grafting. Jin L; Wells JA Protein Sci; 1994 Dec; 3(12):2351-7. PubMed ID: 7538848 [TBL] [Abstract][Full Text] [Related]
35. Receptor recognition and specificity of interleukin-8 is determined by residues that cluster near a surface-accessible hydrophobic pocket. Hammond ME; Shyamala V; Siani MA; Gallegos CA; Feucht PH; Abbott J; Lapointe GR; Moghadam M; Khoja H; Zakel J; Tekamp-Olson P J Biol Chem; 1996 Apr; 271(14):8228-35. PubMed ID: 8626516 [TBL] [Abstract][Full Text] [Related]
36. Molecular basis of the interaction between complement receptor type 2 (CR2/CD21) and Epstein-Barr virus glycoprotein gp350. Young KA; Herbert AP; Barlow PN; Holers VM; Hannan JP J Virol; 2008 Nov; 82(22):11217-27. PubMed ID: 18786993 [TBL] [Abstract][Full Text] [Related]
37. Determination of the functional epitopes of human interleukin-18-binding protein by site-directed mutagenesis. Xiang Y; Moss B J Biol Chem; 2001 May; 276(20):17380-6. PubMed ID: 11278524 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-4 (IL-4) and IL-13 bind to a shared heterodimeric complex on endothelial cells mediating vascular cell adhesion molecule-1 induction in the absence of the common gamma chain. Schnyder B; Lugli S; Feng N; Etter H; Lutz RA; Ryffel B; Sugamura K; Wunderli-Allenspach H; Moser R Blood; 1996 May; 87(10):4286-95. PubMed ID: 8639787 [TBL] [Abstract][Full Text] [Related]
39. Mutagenesis studies of interleukin-8. Identification of a second epitope involved in receptor binding. Williams G; Borkakoti N; Bottomley GA; Cowan I; Fallowfield AG; Jones PS; Kirtland SJ; Price GJ; Price L J Biol Chem; 1996 Apr; 271(16):9579-86. PubMed ID: 8621632 [TBL] [Abstract][Full Text] [Related]
40. Mutational, kinetic, and NMR studies of the roles of conserved glutamate residues and of lysine-39 in the mechanism of the MutT pyrophosphohydrolase. Harris TK; Wu G; Massiah MA; Mildvan AS Biochemistry; 2000 Feb; 39(7):1655-74. PubMed ID: 10677214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]